Literature DB >> 10848967

Activation of phosphatidylinositol 3-kinase by a complex of p59fyn and the receptor tyrosine kinase Xmrk is involved in malignant transformation of pigment cells.

C Wellbrock1, M Schartl.   

Abstract

Malignant melanoma in the fish Xiphophorus is induced by overexpression of the Xmrk-oncogene, encoding a subclass I receptor tyrosine kinase. The mutationally activated Xmrk protein triggers constitutive mitogenic signalling in fish melanoma cells. In recent studies we showed that in melanoma cells phosphatidylinositol (PtdIns) 3-kinase, as well as p59fyn, has elevated levels of kinase activity. Both bind directly to different phosphotyrosine residues in the Xmrk receptor C-terminus through their SH2 domains. To analyse the mechanism of regulation of these Xmrk-associated kinases in melanoma we characterized the protein-protein interactions between PtdIns 3-kinase, p59fyn and the Xmrk receptor in detail. A ternary complex in which the p85 subunit of PtdIns 3-kinase is associated with p59fyn as well as with Xmrk was identified. Contrary to complexes described for other receptors, the adaptor protein p120Cbl was not involved in these interactions. Thus, we describe here a new mechanism of activation of PtdIns 3-kinase by a receptor of the epidermal growth factor receptor family in which p59fyn acts as an adaptor as well as an activator of PtdIns 3-kinase. Activation of PtdIns 3-kinase activity by fyn was also found in vivo. The fact that this was only detectable in highly transformed Xmrk overexpressing melanomas but not in benign lesions points to the essential role of the Xmrk receptor in this mechanism of regulation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10848967     DOI: 10.1046/j.1432-1327.2000.01378.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  14 in total

1.  Comparison of Xiphophorus and human melanoma transcriptomes reveals conserved pathway interactions.

Authors:  Yuan Lu; Mikki Boswell; William Boswell; Susanne Kneitz; Michael Hausmann; Barbara Klotz; Janine Regneri; Markita Savage; Angel Amores; John Postlethwait; Wesley Warren; Manfred Schartl; Ronald Walter
Journal:  Pigment Cell Melanoma Res       Date:  2018-01-29       Impact factor: 4.693

2.  Rapid tyrosine phosphorylation of neuronal proteins including tau and focal adhesion kinase in response to amyloid-beta peptide exposure: involvement of Src family protein kinases.

Authors:  Ritchie Williamson; Timothy Scales; Bruce R Clark; Graham Gibb; C Hugh Reynolds; Stuart Kellie; Ian N Bird; Ian M Varndell; Paul W Sheppard; Ian Everall; Brian H Anderton
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

3.  Apoptosis suppression by Raf-1 and MEK1 requires MEK- and phosphatidylinositol 3-kinase-dependent signals.

Authors:  A von Gise; P Lorenz; C Wellbrock; B Hemmings; F Berberich-Siebelt; U R Rapp; J Troppmair
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

4.  In vitro studies of dasatinib, its targets and predictors of sensitivity.

Authors:  Lucia B Jilaveanu; Christopher R Zito; Saadia A Aziz; Ashok Chakraborty; Michael A Davies; Robert L Camp; David L Rimm; Arkadiusz Dudek; Mario Sznol; Harriet M Kluger
Journal:  Pigment Cell Melanoma Res       Date:  2011-04       Impact factor: 4.693

Review 5.  SRC-family tyrosine kinases in oogenesis, oocyte maturation and fertilization: an evolutionary perspective.

Authors:  William H Kinsey
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

6.  Fyn is a novel target of (-)-epigallocatechin gallate in the inhibition of JB6 Cl41 cell transformation.

Authors:  Zhiwei He; Faqing Tang; Svetlana Ermakova; Ming Li; Qing Zhao; Yong-Yeon Cho; Wei-Ya Ma; Hong-Seok Choi; Ann M Bode; Chung S Yang; Zigang Dong
Journal:  Mol Carcinog       Date:  2008-03       Impact factor: 4.784

7.  Gene expression analysis after receptor tyrosine kinase activation reveals new potential melanoma proteins.

Authors:  Janka Teutschbein; Johannes M Haydn; Birgit Samans; Michael Krause; Martin Eilers; Manfred Schartl; Svenja Meierjohann
Journal:  BMC Cancer       Date:  2010-07-21       Impact factor: 4.430

8.  Combination of MEK and SRC inhibition suppresses melanoma cell growth and invasion.

Authors:  J Ferguson; I Arozarena; M Ehrhardt; C Wellbrock
Journal:  Oncogene       Date:  2012-02-06       Impact factor: 9.867

Review 9.  Xmrks the Spot: Fish Models for Investigating Epidermal Growth Factor Receptor Signaling in Cancer Research.

Authors:  Jerry D Monroe; Faiza Basheer; Yann Gibert
Journal:  Cells       Date:  2021-05-07       Impact factor: 6.600

Review 10.  Beyond the zebrafish: diverse fish species for modeling human disease.

Authors:  Manfred Schartl
Journal:  Dis Model Mech       Date:  2013-11-21       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.